Company Yubo International Biotech Limited Other OTC
Equities
YBGJ
US9883661004
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Health Management and Health Maintenance Services
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +479.84% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +479.84% |
Managers
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Wang Yang
BRD | Director/Board Member | 45 | 01/19/01 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 01/19/01 |
Zhi Hui Bai
BRD | Director/Board Member | 39 | 01/20/01 |
Jun Wang
CEO | Chief Executive Officer | 57 | 01/19/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,447 | 0 | 0 | 6.632 % |
Stock B | 1 | 119,816,343 | 7,945,985 ( 6.632 %) | 0 |
Company contact information
Yubo International Biotech Ltd.
Room 105, Building 5 31 Xishiku Avenue
100034, Beijing
+
http://www.yubogroup.com![address Yubo International Biotech Limited(YBGJ)](https://cdn.zonebourse.com/static/address/236425.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+38.36% | 52.73B | |
+38.99% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |